proline has been researched along with HIV in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bani-Sadr, F; Bourlière, M; Carrat, F; Chalouni, M; de Ledinghen, V; Dorival, C; Esterle, L; Fontaine, H; Lacombe, K; Larrey, D; Marc-Lacombe, J; Pol, S; Salmon, D; Sogni, P; Wittkop, L; Zucman, D | 1 |
| Komatsu, H; Miyata, N; Tachikawa, N; Yoshimura, Y | 1 |
| Liu, W; Lovell, S; Mensa, FJ; Pilot-Matias, T | 1 |
| Fan, H; Fu, Z; Huang, P; Tian, T; Wang, Y; Wu, J; Xia, X; Ye, X; Yue, M; Zhang, Y | 1 |
| Laufer, NL; Rockstroh, JK | 1 |
| Borland, J; Chen, S; Johnson, M; Piscitelli, S; Savina, P; Wynne, B | 1 |
| Bhagani, S; Collado, A; de Los Santos-Gil, I; Delgado, M; Fehr, J; Haberl, A; López-Cortés, LF; Lutz, T; Mandorfer, M; Márquez, M; Mauss, S; Munteanu, DI; Neukam, K; Pineda, JA; Rivero, A; Rivero-Juárez, A; Rockstroh, JK; Scholten, S; Stoeckle, M | 1 |
| Bruno, R; Fagiuoli, S; Sacchi, P | 1 |
| Mayer, KH; Swan, T; Taylor, LE | 1 |
| Challacombe, SJ; Sweet, SP | 1 |
| Bilang, M; Meyer, B; Neffe, AT | 1 |
| Frankel, AD; Tan, R | 1 |
4 review(s) available for proline and HIV
| Article | Year |
|---|---|
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Fibrosis; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Leucine; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Sulfonamides; Treatment Outcome | 2019 |
Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV.
Topics: Aminoisobutyric Acids; Antiviral Agents; Biological Availability; Clinical Trials as Topic; Coinfection; Drug Administration Schedule; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Leucine; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Virus Replication | 2014 |
HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms.
Topics: Antiviral Agents; Coinfection; Disease Progression; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Incidence; Liver Cirrhosis; Mass Screening; Proline; Risk-Taking; RNA, Viral; Sexual Behavior | 2012 |
Oral mucosal immunity and HIV infection: current status.
Topics: Antibodies, Viral; Antiviral Agents; CD8-Positive T-Lymphocytes; Cystatins; Cytokines; Dendritic Cells; Disease Susceptibility; Epithelial Cells; HIV; HIV Infections; Humans; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin A, Secretory; Immunoglobulins; Lactoferrin; Macrophages; Membrane Proteins; Mouth Mucosa; Mucins; Peptides; Proline; Proline-Rich Protein Domains; Proteinase Inhibitory Proteins, Secretory; Proteins; Salivary Proteins and Peptides; T-Lymphocytes | 2002 |
1 trial(s) available for proline and HIV
| Article | Year |
|---|---|
Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir.
Topics: Adult; Aged; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Hepacivirus; Heterocyclic Compounds, 3-Ring; HIV; Humans; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Oxazines; Piperazines; Proline; Pyridones; Young Adult | 2014 |
7 other study(ies) available for proline and HIV
| Article | Year |
|---|---|
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Topics: Antiviral Agents; Cause of Death; Disease Progression; Female; France; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Mortality; Oligopeptides; Proline; Substance-Related Disorders; Sustained Virologic Response | 2021 |
Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Plasma; Proline; Ritonavir; RNA, Viral; Sulfonamides; Valine; Viral Load | 2018 |
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Clinical Trials as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Observational Studies as Topic; Proline; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2019 |
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.
Topics: Adult; Coinfection; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; Treatment Outcome | 2015 |
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; Coinfection; Drug Interactions; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Oligopeptides; Proline; Ribavirin; Serine Proteases; Serine Proteinase Inhibitors; Viral Proteins | 2011 |
Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
Topics: Binding Sites; CD4 Antigens; Databases, Protein; Glycine; HIV; Ligands; Lysine; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Oligopeptides; Peptides; Proline; Threonine; Valine | 2006 |
Structural variety of arginine-rich RNA-binding peptides.
Topics: Amino Acid Sequence; Arginine; Circular Dichroism; Gene Products, tat; HIV; Molecular Sequence Data; Mutation; Peptides; Proline; Protein Conformation; RNA-Binding Proteins; RNA, Viral; tat Gene Products, Human Immunodeficiency Virus | 1995 |